Feifeng Ren
Impact in
-
- Inflammatory Myopathies and Dermatomyositis
Papers in
-
- Inflammatory Myopathies and Dermatomyositis 6
-
- Renin-Angiotensin System Studies 4
- Co-authors
- Wenhan Huang (18 shared papers)Lin Tang (18 shared papers)Jun Zhou (14 shared papers)Lei Luo (12 shared papers)Dongmei Huang (10 shared papers)Lei Luo (6 shared papers)Yaning Zheng (3 shared papers)Jiake Xu (1 shared paper)
In The Last Decade
Feifeng Ren
22 papers receiving 317 citations
Peers
Comparison fields: 5 of 55
- Epidemiology 99
- Nephrology 20
- Cancer Research 32
- Rheumatology 31
- Cardiology and Cardiovascular Medicine 30
Countries citing papers authored by Feifeng Ren
This map shows the geographic impact of Feifeng Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feifeng Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feifeng Ren more than expected).
Fields of papers citing papers by Feifeng Ren
This network shows the impact of papers produced by Feifeng Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feifeng Ren. The network helps show where Feifeng Ren may publish in the future.
Co-authors
The 25 scholars most cited alongside Feifeng Ren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 83 | |
| 2 | 2020 | 42 | |
| 3 | 2015 | 28 | |
| 4 | 2015 | 25 | |
| 5 | 2019 | 25 | |
| 6 | 2015 | 18 | |
| 7 | Clinical features of thirty-two patients with anti-melanoma differentiation-associated gene 5 antibodies. | 2019 | 18 |
| 8 | 2021 | 16 | |
| 9 | 2018 | 16 | |
| 10 | Efficacy and safety of down-titration versus continuation strategies of biological disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis with low disease activity or in remission: a systematic review and meta-analysis. | 2017 | 10 |
| 11 | 2024 | 8 | |
| 12 | 2021 | 7 | |
| 13 | 2022 | 5 | |
| 14 | 2023 | 5 | |
| 15 | 2021 | 3 | |
| 16 | 2022 | 3 | |
| 17 | 2023 | 2 | |
| 18 | 2022 | 2 | |
| 19 | 2023 | 1 | |
| 20 | 2020 | 1 |
About Feifeng Ren
Feifeng Ren is a scholar working on Epidemiology, Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine, Rheumatology and Molecular Biology, having authored 23 papers that have together received 320 indexed citations. Recurring topics across this work include Inflammatory Myopathies and Dermatomyositis (6 papers), Renin-Angiotensin System Studies (4 papers), Vasculitis and related conditions (2 papers), Immunodeficiency and Autoimmune Disorders (2 papers), Receptor Mechanisms and Signaling (2 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers), Eosinophilic Disorders and Syndromes (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). The work is most often cited by research in Epidemiology (99 citations), Nephrology (20 citations), Cancer Research (32 citations), Rheumatology (31 citations) and Cardiology and Cardiovascular Medicine (30 citations). Feifeng Ren has collaborated with scholars based in China, Hong Kong and Australia. Frequent co-authors include Wenhan Huang, Lin Tang, Jun Zhou, Lei Luo, Dongmei Huang, Lei Luo, Yaning Zheng, Jiake Xu, Yue Feng and Baoqing Jia. Their work appears in journals such as Lara D. Veeken, Clinical Rheumatology, Journal of Inflammation Research, Clinical and Experimental Rheumatology and Carcinogenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.